Sleep Health Is Getting Interesting | Out-Of-Pocket
The sleep health market is merging consumer wearables with clinical diagnostics, creating a surge in demand for at‑home screening and management tools. New devices—from Oura rings to at‑home apnea kits—provide continuous biomarkers that flag issues before formal polysomnography. Telemedicine platforms are leveraging this data to deliver virtual sleep clinics, addressing a specialist shortage of roughly 1:43,000 in the U.S. Meanwhile, consumer‑grade interventions such as smart beds, EEG headbands, and sleep‑hygiene apps are opening fresh revenue streams, even as payer coverage remains limited for mild‑moderate conditions.
Citizen Fraud Detection, Self-Experimentation, and OOP Updates | Out-Of-Pocket
The post announces three upcoming healthcare courses—payor contracting, LLM applications, and a US healthcare crash course—each with limited enrollment beginning in December and January. It critiques the stagnant fraud‑waste‑abuse detection market, citing data access barriers and weak incentives, and proposes...
Weird Health Insurance Concepts | Out-Of-Pocket
The article explains three emerging health‑insurance tactics—intercompany eliminations, copay accumulators/maximizers, and reference‑based pricing—that reshape cost flows and patient liabilities. Intercompany eliminations let insurers count payments to owned providers toward medical loss‑ratio requirements, effectively boosting margins. Copay accumulators prevent manufacturer coupons...
Building Trust for Transformation: Rethinking Innovation in Digital Health
The Newcastle upon Tyne Hospitals NHS Trust partnered with Solventum to co‑design an AI‑enabled Follow‑Up Finder tool that screens radiology reports for venous thromboembolism (VTE). By embedding the solution in the electronic patient record, the system achieved over 99.9% sensitivity...
Urinary Leaks: A 12-Week Plan to Eliminate Them
Urinary incontinence affects more than one‑third of women over 40 and up to half of post‑menopausal women, while men see higher rates after prostate surgery. The blog outlines a 12‑week biohacking plan that blends functional pelvic‑floor exercises, targeted nutrition, evidence‑based...
![Understanding the Science Behind Embryo Grading Improves IVF Decision Making [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Design-1-scaled.jpg)
Understanding the Science Behind Embryo Grading Improves IVF Decision Making [PODCAST]
In a KevinMD podcast, reproductive endocrinologist Dr. Erica Bove breaks down embryo grading, contrasting day‑three cell counts with day‑five blastocyst morphology. She explains how labs assess cell number, fragmentation, trophectoderm and inner cell mass to assign grades such as 8A...
Unfinishedness in Medicine: When a Good Visit Feels Incomplete
The article coins the term “unfinishedness” to describe medical visits that are clinically appropriate yet leave patients feeling unresolved. It explains how clinicians often close encounters administratively without sharing the reasoning behind uncertainty, creating a gap between technical success and...
Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin
The FDA has expanded approval of leucovorin calcium tablets as the first therapy for cerebral folate transport deficiency linked to FOLR1 gene variants. The decision relied on published case literature, showing 87‑89% of patients achieved clinical improvement. In oncology, AstraZeneca...
HIMSS 2026 OpenClaw Strikes Back
Day one of HIMSS 2026 highlighted a growing momentum in health‑tech interoperability, with real‑world data exchanges like Clover Health’s CMS network monitor demonstration. The conference underscored pharmacists’ untapped potential as data‑rich care partners, yet noted fragmented systems limit their impact....
Scientists Successfully Freeze and Rewarm Mouse Brain Slices
Researchers at Friedrich‑Alexander‑Universität Erlangen‑Nürnberg successfully vitrified mouse brain slices and, in a limited trial, an entire mouse brain, preserving neuronal structure and function after rewarming. By using a high‑concentration cryoprotective agent cocktail, they avoided ice crystal formation, maintained synaptic architecture,...
Menopause and the Drop in Cervical Cancer Screening
A recent Health and Retirement Study analysis shows that women who have entered menopause are about 24 percent less likely to receive a Pap smear within four years compared with pre‑menopausal peers. This decline coincides with the average cervical‑cancer diagnosis age...
Everything’s Bigger in Texas (Pleading Standard Edition)
The Texas Attorney General filed an opposition to Epic’s motion to dismiss, arguing that Epic cannot import federal summary‑judgment standards into a state‑court pleading under Texas Rule 91a. The brief emphasizes that Epic’s reliance on a patchwork of federal cases...
NX-1607
Nurix Therapeutics has launched NX-1607, the first orally bioavailable small‑molecule inhibitor of the immune regulator CBL‑B, into a Phase 1a/1b trial for advanced cancers. CBL‑B modulates activation of T, B and NK cells, and NX-1607 locks the protein in an inactive...
America versus Alzheimer's
A bipartisan call in Washington urges the United States to make curing Alzheimer’s a flagship scientific enterprise. The proposal calls for billions in basic brain research, Medicare coverage for early diagnosis and preventive treatment starting at age 50, and parity...
Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Deaminet 2026 showcased accelerating advances in base and prime editing, highlighted by rapid Addgene distribution growth and new mechanistic insights such as PE6d’s heightened processivity and ABE8e’s dimer‑driven efficiency. Novel off‑target detection platforms like beCasKAS and Inrich‑seq revealed far more unintended...
Neighbourhood Care: Taking Preventive Health Checks to the Heart of Communities
The Nottingham City Place‑Based Partnership is rolling out neighbourhood‑focused preventive health services to align with the NHS 10‑Year Plan. By deploying free SISU Health Stations in community hubs such as a deprived suburb, a Boots store and a football fan...
Short Films in Focus: “Endless Sea” With Sam Shainberg
Sam Shainberg’s short film “Endless Sea” follows Carol, a flower‑delivery worker, as she scrambles to pay a $365 co‑pay for life‑saving heart medication, exposing the harsh reality of tiered prescription pricing. Set on a rainy Valentine’s Day, the 17‑minute thriller...
The Infiltrator: Recognizing Cardiac Amyloidosis on Echo
Cardiac amyloidosis affects up to a quarter of people over 80 yet remains largely undiagnosed. Characteristic echocardiographic signs—including thickened walls, restrictive filling patterns, and the apical‑sparing strain signature—allow clinicians to suspect the disease early. Differentiating the three amyloid subtypes on...
Who Will Be This Year’s Femtech Company of the Year?
The Femtech Company of the Year award, sponsored by Cross‑Border Impact Ventures (CBIV), seeks to elevate firms that are reshaping women’s health through technology. It recognizes companies tackling reproductive health, maternal care, menopause and related gaps, rewarding exceptional impact and...
Pharma Pulse: Ipsen’s Global Tazemetostat Withdrawal and FDA Approval of Deucravacitinib for Psoriatic Arthritis
French biotech Ipsen announced an immediate, global voluntary withdrawal of its oncology drug tazemetostat (Tazverik) after safety signals in the SYMPHONY‑1 confirmatory trial indicated a rise in secondary hematologic malignancies. The company is coordinating with the FDA to manage the...
Puberty Blockers Were Never Reversible
The blog post contends that puberty‑blocking drugs such as Lupron cause irreversible damage, highlighting a social‑media case of jaw deterioration and enamel loss. It asserts that these medications lead to permanent bone mineral density loss and lifelong health risks, framing...
Government Responds to NICE Regulations Consultation: Cost-Effectiveness Threshold
The UK Department of Health and Social Care has answered its five‑week consultation on NICE regulations by granting ministers a limited power to set the cost‑effectiveness threshold used in technology appraisal (TA) and highly specialised technology (HST) programmes. The change...
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
The FDA has eliminated the longstanding requirement for two pivotal clinical trials, adopting a single‑trial default to speed drug approvals. The agency pairs this change with a mandate for more rigorous post‑market surveillance to catch safety signals after launch. Pharmaceutical...
Researchers Take a Step Closer to Finding a Treatment for a Rare Genetic Neurodevelopmental Condition
Researchers at Texas Children’s Duncan Neurological Research Institute and Baylor College of Medicine demonstrated that skipping exon e2 of the MECP2 gene boosts MeCP2 protein production by 50‑60%, rescuing neuronal function in Rett syndrome mouse models and patient‑derived cells. The study...
Liberal Arts Education As a Counterbalance To Trumpian AI
Amid rising mental‑health crises, policy attacks, and AI‑driven discourse, author Mike Magee argues that a liberal‑arts education offers a vital counterbalance to the divisive Trump era. He highlights how institutions like Le Moyne College embed ethics, history, and critical thinking into...
#597: Behavioral Psychology in Diet & Health Counselling – David Creel, PhD, RD
David Creel, PhD, RD, a clinical psychologist and dietitian at the Cleveland Clinic, emphasizes that lasting weight‑loss hinges on behavioral psychology rather than isolated diet or exercise prescriptions. He outlines a framework that blends collaborative communication, self‑monitoring, skill‑building, and relapse‑prevention...
Interoperability, Half Finished
The article highlights e‑prescribing’s rapid national rollout, which eliminated paper scripts and enabled direct provider‑to‑pharmacy transmission. However, critical gaps remain: pharmacies cannot share real‑time inventory data, and pharmacy‑to‑pharmacy transfers still rely on fax and phone calls. The author’s personal experience—an...
Accrufer Becomes First FDA-Approved Prescription Iron Therapy for Children 10+
Shield Therapeutics announced that the FDA has approved Accrufer, its ferric maltol oral iron formulation, for children ages 10 and older, making it the first prescription oral iron therapy for this age group. The approval expands the drug’s label beyond...
The Dismantling of Public Health in America #CareTalk
The latest #CareTalk episode highlights how decades of chronic underfunding have left America’s public health infrastructure fragile. Dr. Stella Safo of Civic Health Alliance warns that essential health‑security institutions are being dismantled and calls on the healthcare sector to defend...
AI Has Redefined Healthcare Communication — and There’s No Opting Out
Conversational AI tools such as ChatGPT Health and Claude for Healthcare are reshaping how patients and clinicians obtain medical information. OpenAI reports that over 5% of global ChatGPT interactions—about 40 million daily users—are health‑related, while 40% of U.S. healthcare workers use...
Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time
Vinay Prasad has left the FDA’s Center for Biologics Evaluation and Research (CBER) for the second time in under a year, signaling a notable leadership turnover at a key regulatory hub for biologics, vaccines and gene therapies. In parallel, GlaxoSmithKline...
The Quiet Paradox of Physician Mental Health and Medication
Physician wellness leaders are confronting a hidden paradox: while therapy is increasingly normalized, medication use remains stigmatized. Psychiatrist Jessi Gold, chief wellness officer for the University of Tennessee System, disclosed her 13‑year daily Wellbutrin regimen, revealing the pressure physicians feel...
ORN0829
Taisho Pharmaceutical’s vornorexant (TS‑142), marketed as Vorzzz®, received Japanese regulatory approval in August 2025 as a dual orexin‑1/2 receptor antagonist for insomnia. The drug distinguishes itself from existing DORAs through rapid absorption and a short elimination half‑life, aiming to minimize...
The Fully In-Person Physical Therapy Model Is Starting to Crack
The traditional fully in‑person outpatient physical‑therapy model is under strain from tighter reimbursement, staffing shortages, and patients demanding more flexible scheduling. Clinics are turning to hybrid care, combining essential hands‑on visits with short virtual check‑ins to maintain outcomes while improving...
Why Medicine Ignores Its Cassandras: A Case Study in Health Disparities
Developmental‑behavioral pediatrician Ronald L. Lindsay reflects on a 1998 grant that outlined nine concrete goals to address health disparities for children with neurodevelopmental disabilities, women with disabilities, and underserved families. He argues that his early warnings—now framed as a Cassandra‑type...
Pharma Pulse: NCPA’s Medicare Negotiation Overhaul Advocacy and Norgine’s $67M UK Supply Investment
The National Community Pharmacists Association (NCPA) warns that independent pharmacies are facing a cash‑flow crisis as 67% report Medicare drug‑price negotiation refunds delayed 22 days or more, forcing 60% to dip into personal savings. NCPA is urging the Centers for...
The Marketplace Exchanges for Health Insurance
The ACA’s state‑run health‑insurance marketplaces, which require essential benefits and sort plans into Platinum, Gold, Silver and Bronze tiers, covered about 10 million people before COVID‑19. A 2021 expansion of premium tax credits more than doubled enrollment to 23 million and pushed...
We Destroyed One of the Best Health IT Systems Ever Built — and Replaced It With Something Worse
Veterans Affairs’ homegrown VistA electronic health record, praised for usability and clinical outcomes, was replaced by Cerner’s commercial Millennium platform through a sole‑source $10 billion contract. The transition has ballooned to an estimated $37‑$50 billion, far exceeding the roughly $2 billion that modernizing...
Bausch + Lomb Launches R&D “Teach-In” Webinar Series
Bausch + Lomb announced the kickoff of an R&D “Teach‑in” webinar series, beginning with a March 23 session focused on its glaucoma pipeline. Executive Vice President of R&D Yehia Hashad and senior leaders will discuss ELios™, an implant‑free laser glaucoma surgery already launched in...
NIHR Awards £2.31m for Tech Tackling Chronic Condition Progression
The NIHR has granted £2.31 million to 24 projects developing technology‑assisted solutions that stop a single chronic condition from evolving into multi‑morbidity. The funding, delivered via the i4i FAST programme, targets virtual rehabilitation, AI‑driven diagnostics, home monitoring devices and digital self‑management...
A Celebrity Patient and the Core of Patient Confidentiality
Dr. Francisco M. Torres recounts an unexpected encounter with a world‑famous patient who arrived under his legal name, leaving the staff oblivious to his celebrity status. The revelation sparked a flurry of excitement among clinic personnel, yet the physician maintained...
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG...
HeartBeam Inc. announced that its executive team will attend three major investor and industry conferences in March 2026, including Oppenheimer’s virtual MedTech summit, the ROTH conference, and the American College of Cardiology’s ACC.26. The CEO and CFO will present a...
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
Pulse Biosciences reported long‑term results from its first‑in‑human nPulse Vybrance study, showing an average 74% reduction in benign thyroid nodule volume after 15‑22 months. The data, presented at the 2026 North American Society for Interventional Thyroidology meeting, revealed no nodule...
Bristol Myers Squibb Announces Positive Phase 3 Results From the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple...
Bristol Myers Squibb reported positive interim Phase 3 results from the SUCCESSOR‑2 study, showing that oral mezigdomide combined with carfilzomib and dexamethasone (MeziKd) significantly extended progression‑free survival versus carfilzomib‑dexamethasone alone in relapsed or refractory multiple myeloma. The trial marks the first...
Associated Press Cannot Explain Bewildering Reporting on FDA’s Tracy Hoeg and Antidepressant Risks
The Associated Press published a story alleging that FDA senior regulator Dr. Tracy Hoeg was pushing a petition from Dr. Adam Urato to add pregnancy‑risk warnings to antidepressants and that their personal relationship constituted a conflict of interest. The author,...
RFiD Discovery Launches Automated Contact Tracing Solution for Hospitals
RFiD Discovery has introduced an automated contact‑tracing solution for hospitals that leverages Bluetooth Low Energy (BLE) wristbands for patients and BLE‑enabled ID badges for staff. The system captures proximity, duration, distance and location data in real time, feeding it into...
The NHS Doesn’t Have a Productivity Problem: It Has a Precision Problem
The NHS is mislabeling its core challenge as a productivity deficit when the real issue is a lack of precision in deploying clinical expertise. Clinicians spend a disproportionate amount of time on administrative tasks, poor workflows, and unnecessary referrals, eroding...
Bausch+Lomb Chooses Steriline to Improve Production of Ophthalmic Medical Devices
Steriline has delivered its OFCM84 aseptic filling and capping line to Bausch+Lomb Italia to boost eye‑care product output. The line runs at 200 bottles per minute, features CIP/SIP automation, and complies with EU GMP Annex 1 grade‑A cleanroom requirements. Its design...
Epic’s Agent Factory and the End of the Middle Layer: What Health Tech Investors Need to Understand Right Now
At HIMSS26 Epic unveiled Agent Factory, a no‑code, drag‑and‑drop AI builder that lets health systems create and orchestrate autonomous agents across clinical and operational workflows. The move follows Epic’s dominant market position—42.3% of acute‑care hospitals and 54.9% of beds in...
Electric Fields Allow Bioprinting of Aligned Muscle Fibers
Researchers have integrated an electric field into electrohydrodynamic (EHD) bioprinting to orient fibrin‑alginate hydrogels, producing nanofiber alignment that directs myocyte organization. The conductive polymer‑enhanced constructs exhibit improved myotube differentiation and mimic native muscle conductivity. In vivo tests on rats demonstrated...